HB Fuller (NYSE:FUL) had its price target hoisted by Robert W. Baird from $35.00 to $45.00 in a report released on Friday morning, BenzingaRatingsTable reports. Robert W. Baird currently has a neutral rating on the specialty chemicals company’s stock.
Other analysts have also recently issued reports about the stock. JPMorgan Chase & Co. raised shares of HB Fuller from a neutral rating to an overweight rating and set a $34.00 price target on the stock in a research note on Friday, April 17th. Zacks Investment Research cut shares of HB Fuller from a hold rating to a sell rating in a research note on Wednesday, June 24th. Citigroup decreased their price target on shares of HB Fuller from $50.00 to $30.00 and set a neutral rating on the stock in a research note on Friday, March 27th. TheStreet cut shares of HB Fuller from a b- rating to a c+ rating in a research note on Thursday, March 5th. Finally, ValuEngine raised shares of HB Fuller from a sell rating to a hold rating in a research note on Friday, May 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $48.43.
NYSE FUL opened at $42.50 on Friday. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 17.86, a PEG ratio of 2.48 and a beta of 1.81. The company has a 50 day moving average of $39.01 and a 200-day moving average of $40.61. The company has a current ratio of 1.89, a quick ratio of 1.19 and a debt-to-equity ratio of 1.56. HB Fuller has a 1-year low of $23.68 and a 1-year high of $52.40.
HB Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, June 24th. The specialty chemicals company reported $0.68 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.55 by $0.13. HB Fuller had a net margin of 4.43% and a return on equity of 11.89%. The company had revenue of $675.00 million during the quarter, compared to analyst estimates of $664.28 million. During the same quarter last year, the business posted $0.88 earnings per share. The company’s revenue was down 11.2% on a year-over-year basis. On average, analysts forecast that HB Fuller will post 2.35 earnings per share for the current year.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Chevy Chase Trust Holdings Inc. bought a new position in shares of HB Fuller during the fourth quarter worth $27,000. Advisor Group Holdings Inc. bought a new position in shares of HB Fuller during the first quarter worth $27,000. FMR LLC boosted its position in shares of HB Fuller by 37.1% during the fourth quarter. FMR LLC now owns 1,005 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 272 shares in the last quarter. Americana Partners LLC bought a new position in shares of HB Fuller during the fourth quarter worth $59,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of HB Fuller by 367.5% during the first quarter. Tower Research Capital LLC TRC now owns 1,178 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 926 shares in the last quarter. 96.71% of the stock is currently owned by institutional investors.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Featured Article: Why do company’s buyback their stock?
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.